H. Verlooy, M. De Roo, Luc Mortelmans, J. Dequeker
Abstract
Metabolic bone disorders are characterized by a nonspecific increase of Tc-99m MDP uptake in the skeleton. The effects may be generalized and/or local. Here, two clinical entities of secondary hyperparathyroidism are presented— osteomalacia and renal osteodystrophy.
OpenAlex reports 4 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Metabolic bone disorders are characterized by a nonspecific increase of Tc-99m MDP uptake in the skeleton. The effects may be generalized and/or local. Here, two clinical entities of secondary hyperparathyroidism are presented— osteomalacia and renal osteodystrophy.
Key concepts: Osteomalacia, Medicine, Renal osteodystrophy, Secondary hyperparathyroidism, Hyperparathyroidism, Skeleton (computer programming), Bone disease, Internal medicine